Several groups have tested ClpP agonists on immortalized cell lines (i.e., HFF) or primary cells and observed no significant effects on cell proliferation, viability, or apoptosis as compared to the cancer cell models [42,68,75,84]. This evidence concerns the gene CLPP and cancer.